Terms: = Lung cancer AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Prognosis
45 results:
1. [Clinical pathological characteristics analysis of ocular adnexal follicular lymphoma].
Li J; Wang YC; Lin JY
Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):930-936. PubMed ID: 37936361
[No Abstract] [Full Text] [Related]
2. Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index.
Wu R; Ma R; Duan X; Zhang J; Li K; Yu L; Zhang M; Liu P; Wang C
Front Immunol; 2023; 14():1236444. PubMed ID: 37841237
[TBL] [Abstract] [Full Text] [Related]
3. Risk of cardiovascular disease in cancer survivors: A cohort study of 446,384 New Zealand primary care patients.
Tawfiq E; Pylypchuk R; Elwood JM; McKeage M; Wells S; Selak V
Cancer Med; 2023 Oct; 12(19):20081-20093. PubMed ID: 37746882
[TBL] [Abstract] [Full Text] [Related]
4. cancer-associated fibroblasts drive CXCL13 production in activated T cells via TGF-beta.
O'Connor RA; Martinez BR; Koppensteiner L; Mathieson L; Akram AR
Front Immunol; 2023; 14():1221532. PubMed ID: 37520560
[TBL] [Abstract] [Full Text] [Related]
5. Novel models by machine learning to predict prognosis of breast cancer brain metastases.
Li C; Liu M; Zhang Y; Wang Y; Li J; Sun S; Liu X; Wu H; Feng C; Yao P; Jia Y; Zhang Y; Wei X; Wu F; Du C; Zhao X; Zhang S; Qu J
J Transl Med; 2023 Jun; 21(1):404. PubMed ID: 37344847
[TBL] [Abstract] [Full Text] [Related]
6. Serum exosomal m6A demethylase FTO promotes gefitinib resistance in non-small cell lung cancer by up-regulating FLRT3, PTGIS and SIRPα expression.
Wang Q; Zhang L; Su Z; Li W; Jia Y; Zhang J
Pulm Pharmacol Ther; 2023 Oct; 82():102227. PubMed ID: 37330168
[TBL] [Abstract] [Full Text] [Related]
7. Functional status and spatial architecture of tumor-infiltrating CD8+ T cells are associated with lymph node metastases in non-small cell lung cancer.
Yang G; Cai S; Hu M; Li C; Yang L; Zhang W; Sun J; Sun F; Xing L; Sun X
J Transl Med; 2023 May; 21(1):320. PubMed ID: 37173705
[TBL] [Abstract] [Full Text] [Related]
8. Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on T-cell marker genes to predict prognosis and therapeutic response in lung squamous cell carcinoma.
Shi X; Dong A; Jia X; Zheng G; Wang N; Wang Y; Yang C; Lu J; Yang Y
Front Immunol; 2022; 13():992990. PubMed ID: 36311764
[TBL] [Abstract] [Full Text] [Related]
9. Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm.
Stamatis G; Leschber G; Schwarz B; Brintrup DL; Flossdorf S; Passlick B; Hecker E; Kugler C; Eichhorn M; Krbek T; Eggeling S; Hatz R; Müller MR; Hillinger S; Aigner C; Jöckel KH
Lung Cancer; 2022 Oct; 172():108-116. PubMed ID: 36058174
[TBL] [Abstract] [Full Text] [Related]
10. Comprehensive analysis of CXCR family members in lung adenocarcinoma with prognostic values.
Hu LT; Deng WJ; Chu ZS; Sun L; Zhang CB; Lu SZ; Weng JR; Ren QS; Dong XY; Li WD; Li XB; Du YT; Li Y; Wang WQ
BMC Pulm Med; 2022 Jun; 22(1):259. PubMed ID: 35768814
[TBL] [Abstract] [Full Text] [Related]
11. Clinical impact of primary tumor sidedness and sex on unresectable post-recurrence survival in resected pathological stage II-III colorectal cancers: a nationwide multicenter retrospective study.
Abe S; Kawai K; Nozawa H; Sasaki K; Murono K; Emoto S; Ozawa T; Yokoyama Y; Nagai Y; Anzai H; Sonoda H; Yamauchi S; Sugihara K; Ishihara S
BMC Cancer; 2022 May; 22(1):486. PubMed ID: 35501727
[TBL] [Abstract] [Full Text] [Related]
12. A two-phase comprehensive NSCLC prognostic study identifies lncRNAs with significant main effect and interaction.
Zhu J; Guan J; Ji X; Song Y; Xu X; Wang Q; Zhang Q; Guo R; Wang R; Zhang R
Mol Genet Genomics; 2022 Mar; 297(2):591-600. PubMed ID: 35218396
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic and Immunological Role of FAT Family Genes in Non-Small Cell lung cancer.
Feng Z; Yin Y; Liu B; Zheng Y; Shi D; Zhang H; Qin J
Cancer Control; 2022; 29():10732748221076682. PubMed ID: 35212236
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy.
Li C; Pan J; Luo J; Chen X
BMC Pulm Med; 2021 Nov; 21(1):389. PubMed ID: 34844602
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic influence of a ground-glass opacity component in hypermetabolic lung adenocarcinoma.
Hattori A; Matsunaga T; Fukui M; Takamochi K; Suzuki K
Eur J Cardiothorac Surg; 2022 Jan; 61(2):249-256. PubMed ID: 34632486
[TBL] [Abstract] [Full Text] [Related]
16. Treatment response to eribulin and anlotinib in lung metastases from rare perianal adenoid cystic carcinoma: a case report.
Zheng S; Li H; Lin Y; Xie Y; Yin Z; Ge W; Yu T
Anticancer Drugs; 2022 Jan; 33(1):e548-e554. PubMed ID: 34321419
[TBL] [Abstract] [Full Text] [Related]
17. Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index.
Buti S; Bersanelli M; Perrone F; Tiseo M; Tucci M; Adamo V; Stucci LS; Russo A; Tanda ET; Spagnolo F; Rastelli F; Pergolesi F; Santini D; Russano M; Anesi C; Giusti R; Filetti M; Marchetti P; Botticelli A; Gelibter A; Occhipinti MA; Ferrari M; Vitale MG; Nicolardi L; Chiari R; Rijavec E; Nigro O; Tuzi A; De Tursi M; Di Marino P; Conforti F; Queirolo P; Bracarda S; Macrini S; Gori S; Zoratto F; Veltri E; Di Cocco B; Mallardo D; Vitale MG; Santoni M; Patruno L; Porzio G; Ficorella C; Pinato DJ; Ascierto PA; Cortellini A
Eur J Cancer; 2021 Jan; 142():18-28. PubMed ID: 33212418
[TBL] [Abstract] [Full Text] [Related]
18. Preoperative Platelet to Albumin Ratio Predicts Outcome of Patients with Non-Small-Cell lung cancer.
Guo M; Sun T; Zhao Z; Ming L
Ann Thorac Cardiovasc Surg; 2021 Apr; 27(2):84-90. PubMed ID: 33162436
[TBL] [Abstract] [Full Text] [Related]
19. Impact of genetic alterations on outcomes of patients with stage I nonsmall cell lung cancer: An analysis of the cancer genome atlas data.
Xu S; Wang Y; Ren F; Li X; Ren D; Dong M; Chen G; Song Z; Chen J
Cancer Med; 2020 Oct; 9(20):7686-7694. PubMed ID: 32857918
[TBL] [Abstract] [Full Text] [Related]
20. Radiological-pathological correlation of subsolid pulmonary nodules: A single centre retrospective evaluation of the 2011 IASLC adenocarcinoma classification system.
Roberts JM; Greenlaw K; English JC; Mayo JR; Sedlic A
Lung Cancer; 2020 Sep; 147():39-44. PubMed ID: 32659599
[TBL] [Abstract] [Full Text] [Related]
[Next]
